← 產業報告目錄
Lipid-Based Drug Delivery Systems Market Size, Share & Trends Analysis Distribution by Type of Lipid-Based System (Liposomes, Solid Lipid Nanoparticles (SLNs), Nanostructured Lipid Carriers (NLCs), Lipid Nanoparticles (LNPs), Micelles, Lipid-Polymer Hybrid Systems), Application, Route of Administration, Formulation and Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-01頁數 180報告編號 INSIGHTACE-7dd6a299e8
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The global Lipid-Based Drug Delivery Systems Market is projected to witness notable expansion over the coming years.
The Lipid-Based Drug Delivery Systems sector involves intended to increase the delivery and efficacy of drugs that are poorly soluble in water. This domain has witnessed notable transformation owing to technological breakthroughs and shifting healthcare dynamics.
The market's upward path is driven by growing healthcare spending, technological evolution, and the growing focus on personalized and precision-based approaches in healthcare.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region projected to deliver the strongest growth trajectory through the forecast period, driven by demographic shifts and policy support.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Lipid-Based Drug Delivery Systems Market Snapshot
Chapter 4. Global Lipid-Based Drug Delivery Systems Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type of Lipid-Based System Estimates & Trend Analysis
5.1. by Type of Lipid-Based System & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type of Lipid-Based System:
5.2.1. Liposomes
5.2.2. Solid Lipid Nanoparticles (SLNs)
5.2.3. Nanostructured Lipid Carriers (NLCs)
5.2.4. Lipid Nanoparticles (LNPs)
5.2.5. Micelles
5.2.6. Lipid-Polymer Hybrid Systems
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
6.2.1. Oncology
6.2.2. Cardiovascular Diseases
6.2.3. Neurological Disorders
6.2.4. Infectious Diseases
6.2.5. Vaccines
6.2.6. Gene Therapy
6.2.7. Pain Management
Chapter 7. Market Segmentation 3: by Route of Administration Estimates & Trend Analysis
7.1. by Route of Administration & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Route of Administration:
7.2.1. Oral
7.2.2. Parenteral (Intravenous, Intramuscular)
7.2.3. Topical
7.2.4. Pulmonary
7.2.5. Transdermal
Chapter 8. Market Segmentation 4: by Formulation Estimates & Trend Analysis
8.1. by Formulation & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Formulation:
8.2.1. Injectable
8.2.2. Capsules
8.2.3. Emulsions
8.2.4. Ointments
8.2.5. Patches
Chapter 9. Lipid-Based Drug Delivery Systems Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Lipid-Based Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Type of Lipid-Based System, 2024-2031
9.1.2. North America Lipid-Based Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.1.3. North America Lipid-Based Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
9.1.4. North America Lipid-Based Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2024-2031
9.1.5. North America Lipid-Based Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.2. Europe
9.2.1. Europe Lipid-Based Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Type of Lipid-Based System, 2024-2031
9.2.2. Europe Lipid-Based Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.2.3. Europe Lipid-Based Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
9.2.4. Europe Lipid-Based Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2024-2031
9.2.5. Europe Lipid-Based Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Lipid-Based Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Type of Lipid-Based System, 2024-2031
9.3.2. Asia Pacific Lipid-Based Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.3.3. Asia-Pacific Lipid-Based Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
9.3.4. Asia-Pacific Lipid-Based Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2024-2031
9.3.5. Asia Pacific Lipid-Based Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.4. Latin America
9.4.1. Latin America Lipid-Based Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Type of Lipid-Based System, 2024-2031
9.4.2. Latin America Lipid-Based Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.4.3. Latin America Lipid-Based Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
9.4.4. Latin America Lipid-Based Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2024-2031
9.4.5. Latin America Lipid-Based Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Lipid-Based Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Type of Lipid-Based System, 2024-2031
9.5.2. Middle East & Africa Lipid-Based Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.5.3. Middle East & Africa Lipid-Based Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
9.5.4. Middle East & Africa Lipid-Based Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2024-2031
9.5.5. Middle East & Africa Lipid-Based Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Gilead Sciences
10.2.2. Moderna
10.2.3. Pfizer
10.2.4. BioNTech
10.2.5. Johnson & Johnson
10.2.6. Sanofi
10.2.7. Novartis
10.2.8. AstraZeneca
10.2.9. CureVac
10.2.10. Evonik Industries
10.2.11. Lipoid GmbH
10.2.12. Merck KGaA
10.2.13. Exelead
10.2.14. Avanti Polar Lipids (Now Avanti Research)
10.2.15. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們